Obama H, Ozawa M
Department of Biochemistry, Faculty of Medicine, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890, Japan.
J Biol Chem. 1997 Apr 25;272(17):11017-20. doi: 10.1074/jbc.272.17.11017.
alpha-Catenin is a 102-kDa protein exhibiting homology to vincuin, and it forms complexes with cadherins or the tumor-suppressor gene product adenomatous polyposis coli through binding to beta-catenin or plakoglobin (gamma-catenin). The incorporation of alpha-catenin into the cadherin-catenin complexes is a prerequisite for expression of the cell-adhesive activity of cadherins. Using an in vitro assay system involving bacterially expressed proteins, we localized a region in alpha-catenin required for molecular interaction with beta-catenin and plakoglobin. Analysis of various truncated alpha-catenin molecules revealed that amino-terminal residues 48-163 are able to bind to beta-catenin and plakoglobin. Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa. Under the conditions used, beta-catenin bound to alpha-catenin with higher affinity than did plakoglobin. Scatchard analysis indicated that the affinity of the interaction between alpha-catenin and beta-catenin or that between alpha-catenin and plakoglobin was moderately strong (Kd = 3. 8 x 10(-8) and 7.7 x 10(-8), respectively). When transfected into L cells expressing E-cadherin, the amino-terminal region of alpha-catenin (from residue 1 to 226) formed complexes with beta-catenin supporting the in vitro binding experiment results.
α-连环蛋白是一种分子量为102 kDa的蛋白质,与纽蛋白具有同源性,它通过与β-连环蛋白或桥粒珠蛋白(γ-连环蛋白)结合,与钙黏着蛋白或肿瘤抑制基因产物腺瘤性息肉病大肠杆菌形成复合物。α-连环蛋白掺入钙黏着蛋白-连环蛋白复合物是钙黏着蛋白细胞黏附活性表达的前提条件。利用涉及细菌表达蛋白的体外检测系统,我们定位了α-连环蛋白中与β-连环蛋白和桥粒珠蛋白进行分子相互作用所需的区域。对各种截短的α-连环蛋白分子的分析表明,氨基末端残基48 - 163能够与β-连环蛋白和桥粒珠蛋白结合。与β-连环蛋白和桥粒珠蛋白结合到α-连环蛋白同一区域的观察结果一致,β-连环蛋白与桥粒珠蛋白竞争与α-连环蛋白的结合,反之亦然。在所使用的条件下,β-连环蛋白与α-连环蛋白的结合亲和力高于桥粒珠蛋白。Scatchard分析表明,α-连环蛋白与β-连环蛋白之间或α-连环蛋白与桥粒珠蛋白之间相互作用的亲和力适中较强(Kd分别为3.8×10⁻⁸和7.7×10⁻⁸)。当转染到表达E-钙黏着蛋白的L细胞中时,α-连环蛋白的氨基末端区域(从残基1到226)与β-连环蛋白形成复合物,支持了体外结合实验结果。